Synergistic Effect of Theophylline and Procaterol On Interleukin-5-Induced Degranulation from Human Eosinophils

REFERENCES

• Sullivan P., Bekir S., Jaffar Z., Page C., Jeffery P., Costello J. Anti-inflammatory Effects of Low-Dose Oral Theophylline in Atopic Asthma. Lancet 1994; 343: 1006–1008
   PubMed Web of Science ®Google Scholar
• Hendeles L., Harman E., Huang D., O”Brien R., Blake K., Delafuente J. Theophylline Attenuation of Airway Responses to Allergen: Comparison with Cromolyn Metered-Dose Inhaler. J. Allergy Clin. Immunol. 1995; 95: 505–514
   Google Scholar
• Kraft M., Torvik J.A, Trudeau J.B., Wenzel S.E., Martin R.J. Theophylline: Potential Antiinflammatory Effects in Nocturnal Asthma. J. Allergy Clin. Immunol. 1996; 97: 1242–1246
   PubMed Web of Science ®Google Scholar
• Kidney J., Dominguez M., Tayor P.M., Rose M., Chung K.F., Barnes P.J. Immunomodulation by Theophylline in Asthma. Demonstration by Withdrawal of Therapy. Am. J. Respir. Crit. Care Med. 1995; 151: 1907–1914
   PubMedGoogle Scholar
• Ward A.J., McKenniff M., Evans J.M., Page C.P., Costello J.F. Theophylline—An Immunomodulatory Role in Asthma?. Am. Rev. Respir. Dis. 1993; 147: 518–523
   PubMed Web of Science ®Google Scholar
• Sagara H., Fukuda T., Okada T., Ishikawa A., Makino S. Theophylline at Therapeutic Concentration Suppresses PAF-Induced Upregulation of Mac-1 on Human Eosinophils. Clin. Exp. Allergy 1996; 26(suppl 2)16–21
   Google Scholar
• Ohta K., Sawamoto S., Nakajima M., Kubota S., Tanaka Y., Miyasaka T., Nagai A., Hirai K., Mano K., Miyashita H. The Prolonged Survival of Human Eosinophils with Interleukin-5 and Its Inhibition by Theophylline via Apoptosis. Clin. Exp. Allergy 1996; 26(suppl 2)10–15
   Google Scholar
• Jaffar Z.H., Sullivan P., Page C., Costello J. Low-Dose Theophylline Modulates T-Lymphocyte Activation in Allergen-Challenged Asthmatics. Eur. Respir. J. 1996; 9: 456–462
   PubMed Web of Science ®Google Scholar
• Weston M.C., Anderson N., Peachell P.T. Effects of Phosphodiesterase Inhibitors on Human Lung Mast Cell and Basophil Function. Br. J. Pharmacol. 1997; 121: 287–295
   Google Scholar
• Spitzer W.O., Suissa S., Ernst P., Horwitz R.I., Habbick B., Cockcroft D., Boivin J.F., McNutt M., Buist A.S., Rebuck A.S. The Use of Beta-Agonists and the Risk of Death and Near Death from Asthma. N. Engl. J. Med. 1992; 326: 501–506
   PubMed Web of Science ®Google Scholar
• Greening A.P., Ind P.W., Northfield M., Shaw G. Added Salmeterol Versus Higher-Dose Corticosteroid in Asthma Patients with Symptoms on Existing Inhaled Corticosteroid. Lancet 1994; 344: 219–224
   PubMed Web of Science ®Google Scholar
• Yoshimura T., Kurita C., Nagao T., Usami E., Nakao T., Watanabe S., Kobayashi J., Yamazaki F., Tanaka H., Inagaki N., Nagai H. Inhibition of Tumor Necrosis Factor-alpha and Interleukin-1beta Production by Beta-Adrenoceptor Agonists from Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells. Pharmacology 1997; 54: 144–152
   PubMed Web of Science ®Google Scholar
• Okubo Y., Hossain M., Horie S., Momose T., Suzuki J., Isobe M., Sekiguchi M. Inhibitory Effects of Theophylline and Procaterol on Eosinophil Function. Intern. Med. 1997; 36: 276–282
   Google Scholar
• Gleich G.J. Mechanisms of Eosinophil-Associated Inflammation. J. Allergy Clin.Immunol. 2000; 105: 651–663
   PubMed Web of Science ®Google Scholar
• Fujisawa T., Terada A., Atsuta J., Iguchi K., Kamiya H., Sakurai M. IL-5 as a Strong Secretagogue for Human Eosinophils. Int. Arch. Allergy Immunol. 1997; 114: 81–83
   PubMedGoogle Scholar
• Hansel T.T., Pound J.D., Pilling D., Kitas G.D., Salmon M., Gentle T.A., Lee S.S., Thompson R.A. Purification of Human Blood Eosinophils by Negative Selection Using Immunomagnetic Beads. J. Immunol. Methods 1989; 122: 97–103
   Google Scholar
• Fujisawa T., Kato Y., Nagase H., Atsuta J., Terada A., Iguchi K., Kamiya H., Morita Y., Kitaura M., Kawasaki H., Yoshie O., Hirai K. Chemokines Induce Eosinophil Degranulation through CCR-3. J. Allergy Clin. Immunol. 2000; 106: 507–513
   PubMed Web of Science ®Google Scholar
• Eldon M.A., Battle M.M., Coon M.J., Nordblom G.D., Sedman A.J., Colburn W.A. Clinical Pharmacokinetics and Relative Bioavailability of Oral Procaterol. Pharm. Res. 1993; 10: 603–605
   PubMedGoogle Scholar
• Clutterbuck E.J., Shields J.G., Gordon J., Smith S.H., Boyd A., Callard R.E., Campbell H.D., Young I.G., Sanderson C.J. Recombinant Human Interleukin 5 is an Eosinophil Differentiation Factor But Has No Activity in Standard Human B Cell Growth Factor Assays. Eur. J. Immunol. 1987; 17: 1743–1750
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K., Suda T. Highly Purified Murine Interleukin 5 (IL-5) Stimulates Eosinophil Function and Prolongs In Vitro Survival: IL-5 as an Eosinophil Chemotactic Factor. J. Exp. Med. 1988; 167: 1737–1742
   PubMed Web of Science ®Google Scholar
• Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C.J., Gleich G.J. Regulatory Effect of Cytokines on Eosinophil Degranulation. J. Immunol. 1990; 144: 642–646
   PubMed Web of Science ®Google Scholar
• Rothenberg M.E., Petersen J., Stevens R.L., Silberstein D.S., McKenzie D.T., Austen K.F., Owen W.F. IL-5-Dependent Conversion of Normodense Human Eosinophils to the Hypodense Phenotype Uses 3T3 Fibroblasts for Enhanced Viability, Accelerated Hypodensity, and Sustained Antibody-Dependent Cytotoxicity. J. Immunol. 1989; 143: 2311–2316
   PubMed Web of Science ®Google Scholar
• Hamelmann E., Oshiba A., Loader J., Larsen G.L., Gleich G., Lee J., Gelfand E.W. Antiinterleukin-5 Antibody Prevents Airway Hyperresponsiveness in a Murine Model of Airway Sensitization. Am. J. Respir. Crit. Care Med. 1997; 155: 819–825
   PubMed Web of Science ®Google Scholar
• Shi H.Z., Qin S.M., Huang G.W., Chen Y.Q, Xiao C.Q, Xu H., Liang G.R., Xie Z.F., Qin X.Z., Wu J., Li G.X., Zhang C.M. Infiltration of Eosinophils into the Asthmatic Airways Caused by Interleukin 5. Am. J. Respir. Cell. Mol. Biol. 1997; 16: 220–224
   PubMed Web of Science ®Google Scholar
• Humbert M., Corrigan C.J., Kimmitt P., Till S.J., Kay A.B., Durham S.R. Relationship Between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma. Am. J. Respir. Crit. Care Med. 1997; 156: 704–708
   PubMed Web of Science ®Google Scholar
• Robinson D.S., Hamid Q, Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma. N. Engl. J. Med. 1992; 326: 298–304
   PubMed Web of Science ®Google Scholar
• Kita H., Abu-Ghazaleh R.I., Gleich G.J., Abraham R.T. Regulation of Ig-Induced Eosinophil Degranulation by Adenosine 3′,5′-Cyclic Monophosphate. J. Immunol. 1991; 146: 2712–2718
   PubMed Web of Science ®Google Scholar
• Walter S.D., Sackett D.L., Shannon H.S., Levine M., Brownman G.P. Fenoterol and Fatal Asthma. Lancet 1991; 337: 186–187
   Google Scholar
• Vathenen A.S., Knox A.J., Higgins B.G., Britton J.R. Rebound Increase in Bronchial Responsiveness After Treatment with Inhaled Terbutaline. Lancet 1988; 1: 554–557
   PubMed Web of Science ®Google Scholar
• van Schayck C.P., Graafsma S.J., Visch M.B., Dompeling E., van Weel C., Van Herwaarden C.L.A. Increased Bronchial Hyperresponsiveness after Inhaling Salbutamol During 1 Year Is Not Caused by Subsensitization to Salbutamol. J. Allergy Clin. Immunol. 1990; 86: 793–800
   PubMed Web of Science ®Google Scholar
• Szczeklik A., Mastalerz L., Nizankowska E., Cmiel A. Protective and Bronchodilator Effects of Prostaglandin E and Salbutamol in Aspirin-Induced Asthma. Am. J. Respir. Crit. Care Med. 1996; 153: 567–571
   PubMed Web of Science ®Google Scholar
• Sekut L., Champion B.R., Page K., Menius J.R.J.A., Connolly K.M. Anti-inflammatory Activity of Salmeterol: Down-Regulation of Cytokine Production. Clin. Exp. Immunol. 1995; 99: 461–466
   PubMed Web of Science ®Google Scholar
• Eda R., Sugiyama H., Hopp R.J., Okada C., Bewtra A.K., Townley R.G. Inhibitory Effects of Formoterol on Platelet-Activating Factor Induced Eosinophil Chemotaxis and Degranulation. Int. Arch. Allergy Immunol. 1993; 102: 391–398
   Google Scholar
• Coqueret O., Dugas B., Mencia-Huerta J.M., Braquet P. Regulation of IgE Production from Human Mononuclear Cells by β2-Adrenoceptor Agonists. Clin. Exp. Allergy 1995; 25: 304–311
   Google Scholar
• Munoz N.M., Rabe K.F., Vita A.J., Mcallister K., Mayer D., Weiss M., Leff A.R. Paradoxical Blockade of Beta Adrenergically Mediated Inhibition of Stimulated Eosinophil Secretion by Salmeterol. J. Pharmacol. Exp. Ther. 1995; 273: 850–854
   Google Scholar
• Ogawa C., Sano Y. Long-Term Effects of Inhaled Beta 2-Agonists on Bronchial Hyperresponsiveness in Asthmatics. Nippon Rinsho 1996; 54: 3081–3086
   Google Scholar
• Tokuyama K., Arakawa H., Mochizuki H., Morikawa A. Ability of Inhaled Procaterol, a Beta 2 Adrenoceptor Agonist, to Attenuate Eicosanoid-Induced Airflow Obstruction and Airway Microvascular Leakage. Clin. Exp. Allergy 1995; 25: 371–378
   Google Scholar
• Mirza Z.N., Tokuyama K., Arakawa H., Kato M., Mochizuki H., Morikawa A. Inhaled Procaterol Inhibits Histamine-Induced Airflow Obstruction and Microvascular Leakage in Guinea-Pig Airways with Allergic Inflammation. Clin. Exp. Allergy 1998; 28: 644–652
   Google Scholar
• Kondo N., Shinbara M., Inoue R., Fukao T., Kaneko H., Teramoto T., Toshita H. Inhibition of Interferon-γ Production from Lymphocytes Stimu-lated with Food Antigens by a β2-Agonist, Pro-caterol, in Patients with Food-Sensitive Atopic Dermatitis. J. Invest. Allergol. Clin. Immunol. 1997; 7: 225–228
   Google Scholar
• Banner K.H., Page C.P. Theophylline and Selective Phosphodiesterase Inhibitors as Anti-inflammatory Drugs in the Treatment of Bronchial Asthma. Eur. Respir. J. 1995; 8: 996–1000
   PubMed Web of Science ®Google Scholar